AVIM Therapy
Hypertension in pacemaker patients
PivotalActive (BACKBEAT PIVOTAL Trial)
Key Facts
Indication
Hypertension in pacemaker patients
Phase
Pivotal
Status
Active (BACKBEAT PIVOTAL Trial)
Company
About Orchestra BioMed
Orchestra BioMed is a clinical-stage medical device innovator focused on developing and commercializing high-impact therapeutic solutions for hypertension and atherosclerotic artery disease. The company's strategy centers on a capital-efficient, partnership-enabled model to de-risk development and leverage the commercial infrastructure of established partners. Its late-stage pipeline features two flagship platforms: AVIM Therapy, a bioelectronic treatment for hypertension delivered via pacemakers, and Virtue® SAB, a drug/device combination for treating artery disease without a permanent implant.
View full company profile